Page last updated: 2024-10-24

chlorambucil and Iridocyclitis

chlorambucil has been researched along with Iridocyclitis in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Iridocyclitis: Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.

Research Excerpts

ExcerptRelevanceReference
"Chlorambucil was found to be a very potent drug for JCA with acceptable short term, but serious longterm side effects."6.69Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis. ( Savolainen, HA, 1999)
"Chlorambucil was found to be a very potent drug for JCA with acceptable short term, but serious longterm side effects."2.69Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis. ( Savolainen, HA, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savolainen, HA1

Trials

1 trial available for chlorambucil and Iridocyclitis

ArticleYear
Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis.
    The Journal of rheumatology, 1999, Volume: 26, Issue:4

    Topics: Adolescent; Amyloidosis; Antineoplastic Agents, Alkylating; Arthritis, Juvenile; Child; Child, Presc

1999